Emerging Markets Regulatory Tracker: China, India and Russia (Vol. 2 No. 34)
This article was originally published in PharmAsia News
The Emerging Markets Regulatory Tracker is a periodic PharmAsia News feature that summarizes and links to important regulatory developments impacting the biopharma and medical device industries in the Asia Pacific region and other emerging markets.
You may also be interested in...
The granting of fast-track status is a clear signal that the US FDA wants to maintain its high standards of drug and vaccine appraisal.
A new European Directive threatens to disrupt enforcement of the MDR, due in force in May 2021, and could hamper market surveillance and potentially even fragment the single market.
EXACT-Tx will use funds from a NOK155m private placing to harness ultrasound in precision therapeutic targeting across a variety of indications and product classes.